Loading
Medexus Pharmaceuticals Inc. Stock: price and insider trades · Canada
CA·Mcap CA$151.8M
Medexus Pharmaceuticals Inc.: what insiders have been doing
Medexus Pharmaceuticals Inc. is a listed company. Filings by its managers are published through SEDI. 2 insiders have disclosed 128 filings since 18 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of Medexus Pharmaceuticals Inc. has been absent for the past year. Between a trade and the moment it shows up on SEDI, the median delay is 19 days. That lag is the time during which only the insider knows about the trade.
With 128 filings in twelve months, the company is more active than the median of 12 filings across the 2,130 companies we follow on the same exchange.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
128
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,076 of 24,161 companies
40.8
score / 100
Value39
Quality43
FCF yld2.4%
Earn yld-1.6%
EV/EBITDA13.9x
ROE-4.7%
Gross mgn55%
Net mgn-2.4%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$4.83
Analyst consensus
5 analysts1.00/5
CA$6.00Target CA$7.25(+50%)CA$9.00
Income statement
RevenueCA$99.3M
Gross profitCA$54.4M55% margin
EBITDACA$12.7M13% margin
Net income-CA$2.4M-2.3% margin
Valuation
P/Book2.2x
Beta1.73
Balance sheet & cash
Market capCA$151.8M
Total debtCA$22.3M
Free Cash FlowCA$3.7M
Debt / Equity55%
Profitability & ownership
ROE-4.7%
ROA3.0%
% insiders8.0%
% institutions3.3%
Last declaration on 5 October 2026
Declarations128 total
100 sharesCommon SharesTSXSEDI:4786440
100 shares@ CA$5.000.0003% mcap0.0% of flowCommon SharesTSXSEDI:4786438
600 sharesCommon SharesTSXSEDI:4786437
600 shares@ CA$4.990.0020% mcap0.2% of flowCommon SharesTSXSEDI:4786436
4,100 sharesCommon SharesTSXSEDI:4786434
4,100 shares@ CA$4.98830.014% mcap1.1% of flowCommon SharesTSXSEDI:4786432
8,900 sharesCommon SharesTSXSEDI:4786429
8,900 shares@ CA$4.97520.030% mcap2.3% of flowCommon SharesTSXSEDI:4786428
9,800 sharesCommon SharesTSXSEDI:4786426
9,800 shares@ CA$4.95410.033% mcap2.5% of flowCommon SharesTSXSEDI:4786425
200 sharesCommon SharesTSXSEDI:4786424
200 shares@ CA$4.990.0007% mcap0.1% of flowCommon SharesTSXSEDI:4786422
5,000 sharesCommon SharesTSXSEDI:4786421
5,000 shares@ CA$5.000.017% mcap1.3% of flowCommon SharesTSXSEDI:4786420
100 sharesCommon SharesTSXSEDI:4786419
100 shares@ CA$5.000.0003% mcap0.0% of flowCommon SharesTSXSEDI:4786418
10,000 sharesCommon SharesTSXSEDI:4759109
10,000 shares@ CA$4.98950.031% mcap2.8% of flowCommon SharesTSXSEDI:4759108
6,100 sharesCommon SharesTSXSEDI:4759107
6,100 shares@ CA$4.91120.019% mcap1.7% of flowCommon SharesTSXSEDI:4759106
10,000 sharesCommon SharesTSXSEDI:4759105
10,000 shares@ CA$4.83660.031% mcap2.7% of flowCommon SharesTSXSEDI:4759103
8,900 sharesCommon SharesTSXSEDI:4759101
8,900 shares@ CA$4.87630.028% mcap2.4% of flowCommon SharesTSXSEDI:4759100
6,200 sharesCommon SharesTSXSEDI:4759099
25 of 128 declarations
About Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of therapeutic products. It is listed on the Toronto Stock Exchange under the symbol MDX.
